首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1729篇
  免费   124篇
  2024年   2篇
  2023年   28篇
  2022年   34篇
  2021年   36篇
  2020年   48篇
  2019年   62篇
  2018年   94篇
  2017年   92篇
  2016年   75篇
  2015年   65篇
  2014年   68篇
  2013年   200篇
  2012年   93篇
  2011年   112篇
  2010年   53篇
  2009年   67篇
  2008年   97篇
  2007年   98篇
  2006年   72篇
  2005年   65篇
  2004年   64篇
  2003年   54篇
  2002年   56篇
  2001年   18篇
  2000年   21篇
  1999年   19篇
  1998年   16篇
  1997年   11篇
  1996年   14篇
  1995年   12篇
  1994年   11篇
  1993年   5篇
  1992年   8篇
  1991年   4篇
  1990年   8篇
  1989年   4篇
  1988年   9篇
  1987年   4篇
  1986年   2篇
  1985年   5篇
  1983年   5篇
  1982年   8篇
  1981年   4篇
  1980年   7篇
  1979年   5篇
  1978年   5篇
  1977年   3篇
  1976年   2篇
  1964年   1篇
  1960年   1篇
排序方式: 共有1853条查询结果,搜索用时 15 毫秒
151.
Four studies investigated lawyers' concerns that the narrative style of police interviews with adult rape complainants reduces the impact of this interview as video evidence. Study 1 (N = 96) compared mock juror perceptions of simulated evidence‐in‐chief either in traditional short‐answer or narrative style and found testimony style was not a predictor of complainant credibility. Studies 2 (N = 104), 3 (N = 102) and 4 (N = 102) examined different variables that change with testimony style—the number of questions asked, overall testimony length and response length. The number of questions asked was the only predictor of complainant credibility; more questions resulted in higher credibility ratings. These findings suggest that lawyers' concerns about narrative style interviewing are unwarranted. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
152.
153.
154.
Duration is a commonly measured dimension of behavior in behavioral research and clinical practice. An approach to studies of measurement in behavior analysis is to simulate streams of behavior from which samples can be extracted. It is therefore important to establish a typical range and distribution of behavioral durations on which simulated behavioral data should be based. We conducted an analysis of behavioral durations reported in the Journal of Applied Behavior Analysis between 2008 and 2012. The range and distribution of data points across different durations will be presented, as well as an analysis of the reliability of the software used to measure each data point. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
155.
156.
157.
Trends in popular belief about same‐sex relationships have undergone noteworthy change in the United States over the last decade. Yet this change has been marked by stark polarizations and has occurred at varying rates depending upon regional, community, racial, religious, and individual family context. For queer youth and their families, this cultural transformation has broadened opportunities and created a new set of risks and vulnerabilities. At the same time, youth's increasingly open and playful gender fluidity and sexual identity is complicated by unique intersections of class, race, religion, and immigration. Effective family therapy with queer youth requires practitioner's and treatment models that are sensitive to those who bear the burden of multiple oppressions and the hidden resilience embedded in their layered identities. We present case examples of our model of family therapy which addresses refuge, supports difficult dialogs, and nurtures queerness by looking for hidden resilience in the unique intersections of queer youths' lives. These intersections provide transformational potential for youth, their families and even for family therapists as we are all nurtured and challenged to think more complexly about intersectionality, sexuality, and gender.  相似文献   
158.
159.
Pharmaceutical companies are major sponsors of biomedical research. Most scholars and policymakers focus their attention on government and academic oversight activities, however. In this article, I consider the role of pharmaceutical companies’ internal ethics statements in guiding decisions about corporate research and development (R&D). I review materials from drug company websites and contributions from the business and medical ethics literature that address ethical responsibilities of businesses in general and pharmaceutical companies in particular. I discuss positive and negative uses of pharmaceutical companies’ ethics materials and describe shortcomings in the companies’ existing ethics programs. To guide employees and reassure outsiders, companies must add rigor, independence, and transparency to their R&D ethics programs.  相似文献   
160.
Human beings with diminished decision-making capacities are usually thought to require greater protections from the potential harms of research than fully autonomous persons. Animal subjects of research receive lesser protections than any human beings regardless of decision-making capacity. Paradoxically, however, it is precisely animals’ lack of some characteristic human capacities that is commonly invoked to justify using them for human purposes. In other words, for humans lesser capacities correspond to greater protections but for animals the opposite is true. Without explicit justification, it is not clear why or whether this should be the case. Ethics regulations guiding human subject research include principles such as respect for persons—and related duties—that are required as a matter of justice while regulations guiding animal subject research attend only to highly circumscribed considerations of welfare. Further, the regulations guiding research on animals discount any consideration of animal welfare relative to comparable human welfare. This paper explores two of the most promising justifications for these differences␣between the two sets of regulations. The first potential justification points to lesser moral status for animals on the basis of their lesser capacities. The second potential justification relies on a claim about the permissibility of moral partiality as␣found in common morality. While neither potential justification is sufficient to justify the regulatory difference as it stands, there is possible common ground between supporters of some regulatory difference and those rejecting the current difference.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号